Scarica l'app Stockscreener
27.21
1.27%
-0.35
Agios Pharmaceuticals Inc Borsa (AGIO) Ultime notizie
Need To Know: Analysts Are Much More Bullish On Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Revenues - 富途牛牛
AGIO beats on Q1 earnings & sales, stock up 13% on new drug momentum - MSN
Agios Pharmaceuticals Stock Rises 11.2% on Strong Q1 2026 Aqvesme Launch and Pipeline Progress - IndexBox
Agios Pharmaceuticals (AGIO) Is Up 11.2% After Rare Disease Launch And FDA Acceleration NewsHas The Bull Case Changed? - Sahm
Here's Why Shares in Agios Pharmaceuticals Soared This Week (And What to Expect Next in 2026) - The Motley Fool
RBC Capital Sticks to Its Hold Rating for Agios Pharma (AGIO) - The Globe and Mail
MSN Money - MSN
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q1 2026 Earnings Call Transcript - Insider Monkey
Agios Pharmaceuticals Hits Day High with 13.1% Surge in Stock Price - Markets Mojo
Agios Pharmaceuticals Reports 20.7 Million Dollars in Q1 Revenue - HarianBasis.co
AGIO Beats on Q1 Earnings & Sales, Stock Up 13% on New Drug Momentum - The Globe and Mail
Agios (AGIO) Q1 2026 Earnings Call Transcript - AOL.com
AGIO Maintained by Truist Securities -- Price Target Lowered to $36 - GuruFocus
Truist Financial Issues Pessimistic Forecast for Agios Pharmaceuticals (NASDAQ:AGIO) Stock Price - MarketBeat
Agios Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
(AGIO) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Agios Pharmaceuticals Inc (AGIO) Q1 2026 Earnings Call Highlights: Robust Revenue Growth and Strategic Advances - GuruFocus
Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals and other big stocks moving higher on Tuesday - MSN
AGIO SEC FilingsAgios Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Agios Pharmaceuticals, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:AGIO) 2026-04-29 - Seeking Alpha
Agios Pharmaceuticals Q1 2026 Earnings Call Transcript - MarketBeat
Why Agios Pharmaceuticals Stock Zoomed to a 13% Gain on Wednesday - Yahoo Finance
Why Agios Pharmaceuticals Stock Zoomed to a 13% Gain on Wednesday - The Motley Fool
Agios plans Q2 sNDA filing for mitapivat in sickle cell disease while citing >$10B 2030 market opportunity - MSN
Earnings Call Summary | Agios Pharmaceuticals(AGIO.US) Q1 2026 Earnings Conference - 富途牛牛
Vanguard Capital Management (NASDAQ: AGIO) reports 3.09M shares, 5.27% ownership - Stock Titan
Agios Pharmaceuticals (NASDAQ:AGIO) Releases Quarterly Earnings Results, Beats Estimates By $0.12 EPS - MarketBeat
Agios Pharmaceuticals Releases Q1 2026 Financial Results - AlphaStreet
Agios Pharmaceuticals : 2026 Proxy Statement (a7ac5c) - marketscreener.com
AGIO Financials: Income Statement, Balance Sheet & Cash Flow | Agios Pharmaceuticals Inc - Stock Titan
Agios Pharmaceuticals Q1 2026 Financial Results: Net Loss, Revenue, and Key Financial Statements - Minichart
Agios Pharmaceuticals (NASDAQ:AGIO) Shares Gap Up on Earnings Beat - MarketBeat
Agios Pharmaceuticals Q1 Earnings Call Highlights - MarketBeat
Agios Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Agios Pharmaceuticals reports $20.7M revenue, $(1.69) EPS on 10-Q - TradingView
Agios Pharmaceuticals (NASDAQ: AGIO) grows Q1 2026 sales while funding deep rare-disease pipeline - Stock Titan
Earnings call transcript: Agios Q1 2026 earnings soar past expectations By Investing.com - Investing.com Canada
Agios Reports Strong Q1 Revenue Growth and Strategic Advances - GuruFocus
Q1 2026 Agios Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Agios Pharmaceuticals (NASDAQ:AGIO) Q1 2026 Earnings Beat Drives Stock Rally - ChartMill
Earnings Flash (AGIO) Agios Pharmaceuticals Posts Q1 Net Loss $1.69 a Share, vs. FactSet Est of $1.80 Loss - marketscreener.com
Earnings Flash (AGIO) Agios Pharmaceuticals, Inc. Reports Q1 Revenue $20.7M, vs. FactSet Est of $13.3M - marketscreener.com
Agios Reports First Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Agios Pharmaceuticals: Q1 Earnings Snapshot - marketscreener.com
Agios (NASDAQ: AGIO) doubles mitapivat revenue and funds 2026 pipeline catalysts - Stock Titan
New thalassemia drug writes 242 U.S. scripts as Agios plans sickle cell filing - Stock Titan
Here's why Agios Pharmaceuticals stock slumped this week (and what investors have to look forward to in 2026) - MSN
Agios Pharmaceuticals (AGIO) Heavy EPS Loss Tests Growth‑Led Bullish Narratives Heading Into Q1 2026 - Sahm
Agios Pharmaceuticals Q1 2026 earnings preview - MSN
Q3 2025 Agios Pharmaceuticals Inc Earnings Call Transcript - GuruFocus
Agios falls as Leerink cites deaths linked to lead asset Pyrukynd - MSN
BofA Reaffirms Buy Rating for Agios Pharmaceuticals (AGIO) - Insider Monkey
10 Oversold Small Cap Stocks to Buy Now - Insider Monkey
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Agios (AGIO) Q2 2025 Earnings Call Transcript - AOL.com
[ARS] AGIOS PHARMACEUTICALS, INC. SEC Filing - Stock Titan
Agios Pharmaceuticals (NASDAQ: AGIO) outlines 2026 virtual meeting, director elections and plan amendment - Stock Titan
Do Upbeat EPS Revisions Before Earnings Quietly Reframe Agios Pharmaceuticals’ (AGIO) Risk‑Reward Profile? - Yahoo Finance
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):